School of Medicine
From driving cutting-edge research to bringing medical innovations to market, landing competitive awards and more, the faculty, staff and students at Case Western Reserve University School of Medicine know how to make headlines.
Hero Type
Image
Cleveland research team identifies key driver of age-related cognitive decline
Researchers from University Hospitals, Case Western Reserve University and the Cleveland VA published preclinical results in Proceedings of the National Academy of Sciences (PNAS)
Recent News
August 12, 2019
Outlet: Crain's Cleveland Business
August 09, 2019
Outlet: Crain's Cleveland Business
August 08, 2019
There is no cure for the more than 1.6 million people in the United States living with Crohn’s disease (CD) and its symptoms, including abdominal pain, intestinal distress and severe weight-loss. CD is a form of inflammatory bowel disease (IBD) in which the body’s own immune system attacks the…
August 06, 2019
CWRU team will provide policy recommendations for balancing safety, innovation While federal and professional regulatory systems monitor genetic-editing experiments in university and corporate labs, most research conducted outside of these settings lacks formal oversight. Now, two Case Western…
August 05, 2019
An admissions director on putting your best foot forward Medical School Headquarters: Christian Essman, director of admissions at the School of Medicine, weighed in on the medical school admissions process and gave tips to students as they navigate the application process.
August 02, 2019
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer’s disease, Parkinson’s disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive…
July 30, 2019
Convelo Therapeutics Inc., a Cleveland company based on the research findings of Paul Tesar and Drew Adams at the Case Western Reserve University School of Medicine, has entered into a strategic partnership with Genentech to develop new therapeutic drugs to repair damaged myelin insulation on nerve…
July 29, 2019
Acute lymphoblastic leukemia accounts for one in five adult leukemias, and is the most common pediatric cancer in the United States. While new immune therapies have helped improve survival rates, some patients are unresponsive to existing treatment regimens. In addition, drug-related toxicities and…